Literature DB >> 33476475

Delirium in acute stroke: A prospective, cross-sectional, cohort study.

Eleonora Rollo1, Antonio Callea1, Valerio Brunetti2, Catello Vollono2, Jessica Marotta2, Claudio Imperatori3, Giovanni Frisullo2, Aldobrando Broccolini1,2, Giacomo Della Marca1,2.   

Abstract

BACKGROUND AND
PURPOSE: Delirium is a neuropsychiatric disorder of attention and awareness that develops over a short time and fluctuates in severity. Although delirium has been extensively studied in intensive care units, the incidence of delirium in stroke units and its predictors in stroke patients need further investigation. The endpoints of our study were incidence of delirium in acute stroke and the risk factors that predispose to this condition.
METHODS: Patients were consecutively enrolled in a stroke unit from April to October 2020. Inclusion criteria were: age ≥18 years, acute stroke and National Institute of Health Stroke Scale (NIHSS) score ≥1 at the time of clinical assessment of delirium. Exclusion criteria were: transient ischemic attack; absence of neuroimaging evidence of brain lesion; cerebral venous thrombosis; subarachnoid hemorrhage; and clinical conditions requiring intensive care unit treatment. All patients were evaluated by means of Richmond Agitation-Sedation Scale (RASS) and Confusion Assessment Method-Intensive Care Unit (CAM-ICU) scores at baseline, evaluations which were repeated within 72 h or when patients developed symptoms suggesting delirium.
RESULTS: The overall incidence of delirium was 36/120 (30%). Delirium was associated with aphasia (odds ratio [OR] 9.77; confidence interval [CI] 1.2-79.6), chronic obstructive pulmonary disease (COPD; OR 16.67; CI 1.1-263.0), deep Fazekas score (OR 5.05; CI 1.7-14.8), and physical restraint (OR 45.02; CI 1.4-1411.5). Diabetes was associated with a lower incidence of delirium (OR 0.04; CI 0.026-0.7).
CONCLUSIONS: Nearly one-third of patients (30%) had delirium in the acute phase of stroke. This finding supports the notion that delirium is a common complication of stroke. Delirium was associated with speech disorder, leukoencephalopathy, COPD and early use of physical restraint.
© 2021 European Academy of Neurology.

Entities:  

Keywords:  CAM-ICU; delirium; physical restraint; risk factors; stroke; stroke unit

Year:  2021        PMID: 33476475     DOI: 10.1111/ene.14749

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  5 in total

1.  Impact of delirium on the outcome of stroke: a prospective, observational, cohort study.

Authors:  Eleonora Rollo; Valerio Brunetti; Irene Scala; Antonio Callea; Jessica Marotta; Catello Vollono; Giovanni Frisullo; Aldobrando Broccolini; Paolo Calabresi; Giacomo Della Marca
Journal:  J Neurol       Date:  2022-08-09       Impact factor: 6.682

2.  Delirium in elderly patients with COPD combined with respiratory failure undergoing mechanical ventilation: a prospective cohort study.

Authors:  Xuecai Fu; Lina Wang; Guihua Wang; Xuefang Liu; Xin Wang; Shuiting Ma; Fengru Miao
Journal:  BMC Pulm Med       Date:  2022-07-09       Impact factor: 3.320

3.  Associations Between Stroke Localization and Delirium: A Systematic Review and Meta-Analysis.

Authors:  John Y Rhee; Mia A Colman; Maanasa Mendu; Simran J Shah; Michael D Fox; Natalia S Rost; Eyal Y Kimchi
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-12-23       Impact factor: 2.136

4.  Heart rate variability and delirium in acute non-cardioembolic stroke: a prospective, cross-sectional, cohort study.

Authors:  Eleonora Rollo; Jessica Marotta; Antonio Callea; Valerio Brunetti; Catello Vollono; Irene Scala; Claudio Imperatori; Giovanni Frisullo; Aldobrando Broccolini; Giacomo Della Marca
Journal:  Neurol Sci       Date:  2021-09-29       Impact factor: 3.830

Review 5.  The Role of Vascular Risk Factors in Post-Stroke Delirium: A Systematic Review and Meta-Analysis.

Authors:  Vasileios Siokas; Robert Fleischmann; Katharina Feil; Ioannis Liampas; Markus C Kowarik; Yang Bai; Maria-Ioanna Stefanou; Sven Poli; Ulf Ziemann; Efthimios Dardiotis; Annerose Mengel
Journal:  J Clin Med       Date:  2022-10-01       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.